These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 21122661)

  • 1. No evidence of impaired endothelial function or altered inflammatory state in patients with familial hypercholesterolemia treated with statins.
    Hovland A; Aagnes I; Brekke OL; Flage JH; Lappegård KT
    J Clin Lipidol; 2010; 4(4):288-92. PubMed ID: 21122661
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inflammatory and thrombotic processes are associated with vascular dysfunction in children with familial hypercholesterolemia.
    Charakida M; Tousoulis D; Skoumas I; Pitsavos C; Vasiliadou C; Stefanadi E; Antoniades C; Latsios G; Siasos G; Stefanadis C
    Atherosclerosis; 2009 Jun; 204(2):532-7. PubMed ID: 19004443
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Addition of marine omega-3 fatty acids to statins in familial hypercholesterolemia does not affect in vivo or in vitro endothelial function.
    Hande LN; Thunhaug H; Enebakk T; Ludviksen J; Pettersen K; Hovland A; Lappegård KT
    J Clin Lipidol; 2019; 13(5):762-770. PubMed ID: 31543373
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated serum levels of proinflammatory cytokines and biomarkers of matrix remodeling in never-treated patients with familial hypercholesterolemia.
    El Messal M; Beaudeux JL; Drissi A; Giral P; Chater R; Bruckert E; Adlouni A; Chapman MJ
    Clin Chim Acta; 2006 Apr; 366(1-2):185-9. PubMed ID: 16280123
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cholesterol lowering is more important than pleiotropic effects of statins for endothelial function in patients with dysglycaemia and coronary artery disease.
    Settergren M; Böhm F; Rydén L; Pernow J
    Eur Heart J; 2008 Jul; 29(14):1753-60. PubMed ID: 18441323
    [TBL] [Abstract][Full Text] [Related]  

  • 6. One-year atorvastatin treatment in hypercholesterolemic patients with or without carotid artery disease.
    Avellone G; Di Garbo V; Abruzzese G; Campisi D; De Simone R; Raneli G; Licata G
    Int Angiol; 2006 Mar; 25(1):26-34. PubMed ID: 16520721
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapid effect of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibition on coronary endothelial function.
    Wassmann S; Faul A; Hennen B; Scheller B; Böhm M; Nickenig G
    Circ Res; 2003 Oct; 93(9):e98-103. PubMed ID: 14551237
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of combined administration of low dose atorvastatin and vitamin E on inflammatory markers and endothelial function in patients with heart failure.
    Tousoulis D; Antoniades C; Vassiliadou C; Toutouza M; Pitsavos C; Tentolouris C; Trikas A; Stefanadis C
    Eur J Heart Fail; 2005 Dec; 7(7):1126-32. PubMed ID: 16051518
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Premature cardiovascular disease in young women with heterozygous familial hypercholesterolemia.
    van der Graaf A; Hutten BA; Kastelein JJ; Vissers MN
    Expert Rev Cardiovasc Ther; 2006 May; 4(3):345-51. PubMed ID: 16716095
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Colesevelam added to combination therapy with a statin and ezetimibe in patients with familial hypercholesterolemia: a 12-week, multicenter, randomized, double-blind, controlled trial.
    Huijgen R; Abbink EJ; Bruckert E; Stalenhoef AF; Imholz BP; Durrington PN; Trip MD; Eriksson M; Visseren FL; Schaefer JR; Kastelein JJ;
    Clin Ther; 2010 Apr; 32(4):615-25. PubMed ID: 20435231
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased inflammatory markers in children with familial hypercholesterolaemia.
    Ueland T; Vissers MN; Wiegman A; Rodenburg J; Hutten B; Gullestad L; Ose L; Rifai N; Ridker PM; Kastelein JJ; Aukrust P; Semb AG
    Eur J Clin Invest; 2006 Mar; 36(3):147-52. PubMed ID: 16506958
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Familial hypercholesterolemia: current treatment and advances in management.
    Huijgen R; Vissers MN; Defesche JC; Lansberg PJ; Kastelein JJ; Hutten BA
    Expert Rev Cardiovasc Ther; 2008 Apr; 6(4):567-81. PubMed ID: 18402545
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Residual effects of lovastatin and simvastatin on urinary mevalonate excretions in patients with familial hypercholesterolemia.
    Pappu AS; Bacon SP; Illingworth DR
    J Lab Clin Med; 2003 Apr; 141(4):250-6. PubMed ID: 12677170
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Familial hypercholesterolemia patients treated with statins at no increased risk for intracranial vascular lesions despite increased cholesterol burden and extracranial atherosclerosis.
    Soljanlahti S; Autti T; Lauerma K; Raininko R; Keto P; Turtola H; Vuorio AF
    Stroke; 2005 Jul; 36(7):1572-4. PubMed ID: 15933262
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of statins in endothelial dysfunction in hypertension.
    Sarkar K; Sinha AK; Mehta JL
    Curr Opin Cardiol; 2006 Jul; 21(4):316-21. PubMed ID: 16755200
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improved endothelial function with simvastatin but unchanged insulin sensitivity with simvastatin or ezetimibe.
    Kater AL; Batista MC; Ferreira SR
    Metabolism; 2010 Jun; 59(6):921-6. PubMed ID: 20199786
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of atorvastatin therapy and conversion to tacrolimus on hypercholesterolemia and endothelial dysfunction after renal transplantation.
    Wissing KM; Unger P; Ghisdal L; Broeders N; Berkenboom G; Carpentier Y; Abramowicz D
    Transplantation; 2006 Sep; 82(6):771-8. PubMed ID: 17006324
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [About: pleiotropic effects of statins in atherosclerosis].
    Ambrosi P
    Arch Mal Coeur Vaiss; 2005 Dec; 98(12):1263; author reply 1263-5. PubMed ID: 16435610
    [No Abstract]   [Full Text] [Related]  

  • 19. Neutral effect on markers of heart failure, inflammation, endothelial activation and function, and vagal tone after high-dose HMG-CoA reductase inhibition in non-diabetic patients with non-ischemic cardiomyopathy and average low-density lipoprotein level.
    Bleske BE; Nicklas JM; Bard RL; Brook RD; Gurbel PA; Bliden KP; Rajagopalan S; Pitt B
    J Am Coll Cardiol; 2006 Jan; 47(2):338-41. PubMed ID: 16412857
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Familial hypercholesterolemia: a decade of progress.
    Gidding SS
    J Pediatr; 2010 Feb; 156(2):176-7. PubMed ID: 20105635
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.